11-Hidroxitetrahidrocannabinol (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "11-Hidroxitetrahidrocannabinol" in Spanish language version.

refsWebsite

Global rank Spanish rank

10nih.gov

4^th place

7doi.org

2^nd place

4archive.org

6^th place

5^th place

1druglibrary.org

low place

1scielo.br

1,606^th place

738^th place

1thecannabist.co

low place

archive.org

Turkanis SA, Karler R (1988). «Changes in neurotransmitter release at a neuromuscular junction of the lobster caused by cannabinoids». Neuropharmacology 27 (7): 737-42. PMID 2901683. doi:10.1016/0028-3908(88)90083-4.
Hollister LE, Gillespie HK (1975). «Action of delta-9-tetrahydrocannabinol. An approach to the active metabolite hypothesis». Clin. Pharmacol. Ther. 18 (6): 714-9. PMID 1204277.
Lemberger, L; Martz, R; Rodda, B; Forney, R; Rowe, H (1973). «Comparative Pharmacology of Δ9-Tetrahydrocannabinol and its Metabolite, 11-OH-Δ9-Tetrahydrocannabinol». The Journal of Clinical Investigation 52 (10): 2411-7. PMC 302499. PMID 4729039. doi:10.1172/JCI107431.
«Δ9-Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC». Clin. Chem. 55: 2180-9. diciembre de 2009. PMC 3196989. PMID 19833841. doi:10.1373/clinchem.2008.122119.

doi.org

dx.doi.org

Johnson JR, Jennison TA, Peat MA, Foltz RL (1984). «Stability of delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in blood and plasma». Journal of analytical toxicology 8 (5): 202-4. PMID 6094914. doi:10.1093/jat/8.5.202.
Turkanis SA, Karler R (1988). «Changes in neurotransmitter release at a neuromuscular junction of the lobster caused by cannabinoids». Neuropharmacology 27 (7): 737-42. PMID 2901683. doi:10.1016/0028-3908(88)90083-4.
Lemberger, L; Martz, R; Rodda, B; Forney, R; Rowe, H (1973). «Comparative Pharmacology of Δ9-Tetrahydrocannabinol and its Metabolite, 11-OH-Δ9-Tetrahydrocannabinol». The Journal of Clinical Investigation 52 (10): 2411-7. PMC 302499. PMID 4729039. doi:10.1172/JCI107431.
Baker PB, Taylor BJ, Gough TA. (Jun 1981), «The tetrahydrocannabinol and tetrahydrocannabinolic acid content of cannabis products», Journal of Pharmacy and Pharmacology 33 (6): 369-72, PMID 6115009, doi:10.1111/j.2042-7158.1981.tb13806.x .
Sirikantaramas S, Morimoto S, Shoyama Y, Ishikawa Y, Wada Y, Shoyama Y, Taura F. (17 de septiembre de 2004), «The gene controlling marijuana psychoactivity: molecular cloning and heterologous expression of Delta1-tetrahydrocannabinolic acid synthase from Cannabis sativa L.», Journal of Biological Chemistry 279 (38): 39767-74, PMID 15190053, doi:10.1074/jbc.M403693200 .
Moore C, Rana S, Coulter C. (1 de junio de 2007), «Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid», J Chromatogr B Analyt Technol Biomed Life Sci. 852 (1-2): 459-64, PMID 17321807, doi:10.1016/j.jchromb.2007.02.016 .
«Δ9-Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC». Clin. Chem. 55: 2180-9. diciembre de 2009. PMC 3196989. PMID 19833841. doi:10.1373/clinchem.2008.122119.

druglibrary.org

Government Marijuana Researcher Speaks Favorably About Marijuana's Medical Utility NORML September 26, 1996.

nih.gov

ncbi.nlm.nih.gov

Johnson JR, Jennison TA, Peat MA, Foltz RL (1984). «Stability of delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in blood and plasma». Journal of analytical toxicology 8 (5): 202-4. PMID 6094914. doi:10.1093/jat/8.5.202.
Turkanis SA, Karler R (1988). «Changes in neurotransmitter release at a neuromuscular junction of the lobster caused by cannabinoids». Neuropharmacology 27 (7): 737-42. PMID 2901683. doi:10.1016/0028-3908(88)90083-4.
Hollister LE, Gillespie HK (1975). «Action of delta-9-tetrahydrocannabinol. An approach to the active metabolite hypothesis». Clin. Pharmacol. Ther. 18 (6): 714-9. PMID 1204277.
Lemberger, L; Martz, R; Rodda, B; Forney, R; Rowe, H (1973). «Comparative Pharmacology of Δ9-Tetrahydrocannabinol and its Metabolite, 11-OH-Δ9-Tetrahydrocannabinol». The Journal of Clinical Investigation 52 (10): 2411-7. PMC 302499. PMID 4729039. doi:10.1172/JCI107431.
Baker PB, Taylor BJ, Gough TA. (Jun 1981), «The tetrahydrocannabinol and tetrahydrocannabinolic acid content of cannabis products», Journal of Pharmacy and Pharmacology 33 (6): 369-72, PMID 6115009, doi:10.1111/j.2042-7158.1981.tb13806.x .
Sirikantaramas S, Morimoto S, Shoyama Y, Ishikawa Y, Wada Y, Shoyama Y, Taura F. (17 de septiembre de 2004), «The gene controlling marijuana psychoactivity: molecular cloning and heterologous expression of Delta1-tetrahydrocannabinolic acid synthase from Cannabis sativa L.», Journal of Biological Chemistry 279 (38): 39767-74, PMID 15190053, doi:10.1074/jbc.M403693200 .
Moore C, Rana S, Coulter C. (1 de junio de 2007), «Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid», J Chromatogr B Analyt Technol Biomed Life Sci. 852 (1-2): 459-64, PMID 17321807, doi:10.1016/j.jchromb.2007.02.016 .
Taura F. (Jun 2009), «Studies on tetrahydrocannabinolic acid synthase that produces the acidic precursor of tetrahydrocannabinol, the pharmacologically active cannabinoid in marijuana», Drug Discoveries and Therapeutics 3 (3): 83-7, PMID 22495534 .
«Δ9-Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC». Clin. Chem. 55: 2180-9. diciembre de 2009. PMC 3196989. PMID 19833841. doi:10.1373/clinchem.2008.122119.
The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):178S-189S.

scielo.br

Possible hepatotoxicity of chronic marijuana usage Sao Paulo Med. J. vol.122 no.3 São Paulo May 2004.

thecannabist.co

Dazed & Infused: Five legit reasons why an edible’s high is unpredictable